[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100533576":3},{"organization":4,"outcomesModule":7,"designInfo":17,"detailedDescription":16,"studyPopulation":20,"armGroups":16,"interventions":16,"overallOfficials":16,"centralContacts":16,"locations":21,"responsibleParty":50,"collaborators":16,"id":52,"slug":16,"hasResults":53,"nctId":54,"briefTitle":55,"officialTitle":55,"acronym":16,"eligibilityCriteria":56,"healthyVolunteers":53,"sex":57,"minAge":58,"maxAge":16,"enrollmentInfo":59,"targetDuration":16,"studyType":62,"phases":16,"briefSummary":63,"conditions":64,"keywords":16,"overallStatus":24,"whyStopped":16,"lastUpdateSubmitDate":66,"lastUpdatePostDateStruct":67,"startDateStruct":70,"completionDateStruct":72,"leadSponsor":74,"locationsCount":75},{"fullName":5,"class":6},"Fondazione G.B. Bietti, IRCCS","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":16},[9],{"measure":10,"description":11,"timeFrame":12},"the agreement between 10-2 HFA and 24-2c HFA in detecting central visual field defect","central visual field is defined by the presence of a cluster of three test locations with significantly reduced sensitivity in a hemifield fo the pattern deviation plot.","12 month",[14],{"measure":15,"description":11,"timeFrame":12},"the agreement between 24-2c HFA and G1 Octopus in detecting central visual field defect",null,{"allocation":16,"interventionModel":16,"interventionModelDescription":16,"primaryPurpose":16,"observationalModel":18,"timePerspective":19,"maskingInfo":16},"COHORT","CROSS_SECTIONAL","glaucoma patients referring to glaucoma clinic of IRCCS-Fondazione GB Bietti and University of Rome Tor Vergata.",[22,40],{"facility":23,"status":24,"city":25,"state":16,"zip":16,"country":26,"countryCode":27,"cosmosGeoPoint":28,"geoPoint":33,"contacts":34},"IRCCS-Fondazione GB Bietti","RECRUITING","Rome","Italy","IT",{"type":29,"coordinates":30},"Point",[31,32],12.51133,41.89193,{"lat":32,"lon":31},[35],{"name":36,"role":37,"phone":38,"phoneExt":16,"email":39},"Gloria Roberti, PhD","CONTACT","+390685356727","gloria.roberti@fondazionebietti.it",{"facility":41,"status":24,"city":25,"state":16,"zip":16,"country":26,"countryCode":27,"cosmosGeoPoint":42,"geoPoint":44,"contacts":45},"University of Rome Tor Vergata",{"type":29,"coordinates":43},[31,32],{"lat":32,"lon":31},[46],{"name":47,"role":37,"phone":48,"phoneExt":16,"email":49},"Gianluca Manni, MD","+3906209001","gianlucamanni53@gmail.com",{"type":51,"investigatorFullName":16,"investigatorTitle":16,"investigatorAffiliation":16,"oldNameTitle":16,"oldOrganization":16},"SPONSOR","100533576",false,"NCT06227611","Evaluation of Different Perimetric Grids to Detect Central Visual Field Defect in Glaucoma Patients with Reduce Ganglion Cell Layer Thickness Measured by Spectral Domain OCT.","Inclusion Criteria:\n\n* glaucoma patients with glaucomatous optic nerve head defect and reduced ganglion cell layer thickness\n\nExclusion Criteria:\n\n* age\\\u003C18 years\n* unable to read, understand and sign the written informed consent\n* unable to perform visual field test\n* advanced glaucoma with C\u002FD\\>0.7\n* other causes of optic neuropathies\n* retinal or macular diseases\n* lens or corneal opacities\n* spherical refractive defect \\>± 6D\n* cylindric refractive defect \\>± 3D","ALL","18 Years",{"count":60,"type":61},16,"ESTIMATED","OBSERVATIONAL","The aim of the study is to evaluate the agreement between three different grids in detecting central visual field defect in early glaucoma patients with reduced ganglion cell layer thickness.",[65],"Glaucoma","2025-02-25",{"date":68,"type":69},"2025-02-27","ACTUAL",{"date":71,"type":69},"2021-05-04",{"date":73,"type":61},"2025-05-04",{"name":5,"class":6},2]